Skip to main content

Table 3 Medications taken for chronic migraine prior to occipital nerve stimulation

From: Long-term outcomes of occipital nerve stimulation for chronic migraine: a cohort of 53 patients

  Number of patients who tried drug (% of cohort n = 53) Daily dose range (mg) Mean maximum daily dose (mg)
Beta-Blockers 42 (79.2 %) 30–320 140.80
Topiramate 49 (92.4 %) 25–400 170.65
Sodium Valproate 47 (88.6 %) 300–2500 1047.50
Gabapentin 51 (96.2 %) 300–3600 2206.97
Pregabalin 32 (60.3 %) 50–600 384.16
Flunarizine 36 (67.9 %) 5–20 8.79
Pizotifen 45 (84.9 %) 1.5–4.5 2.39
Methysergide 44 (83.0 %) 1–12 6.10
Tricyclic Antidepressant: 51 (96.2 %)
 Amitriptyline 44 (83.0 %) 10–150 56.31
 Dosulepin 28 (52.8 %) 25–225 101.73
NSAID 42 (79.2 %)
Acupuncture 3 (5.7 %)
Botox 7 (13.2 %)
IV DHE 45 (84.9 %)
GONB 53 (100 %)
  1. Botox OnabotulinumtoxinA, DHE Dihydroergotamine, GONB greater occipital nerve block, IV intravenous, NSAID non-steroidal anti-inflammatory drug